Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia
Clinical trial NCT04566484 · TERMINATED
Trial details
- NCT number
- NCT04566484
- Sponsor
- International Vaccine Institute
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2022-07-19
- Enrollment
- 3210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.